Ensign Peak Advisors
SRNE

Ensign Peak Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Ensign Peak Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-88,990
Closed -$414K – 2264
2021
Q4 		$414K Buy
+88,990
New +$414K ﹤0.01% 1691